|
VDAC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.624810E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.789610E-01 |
| Normal-vs-Stage2 |
9.360400E-01 |
| Normal-vs-Stage3 |
6.066400E-01 |
| Normal-vs-Stage4 |
9.912800E-01 |
| Stage1-vs-Stage2 |
4.729200E-01 |
| Stage1-vs-Stage3 |
2.295800E-01 |
| Stage1-vs-Stage4 |
5.466400E-01 |
| Stage2-vs-Stage3 |
6.411400E-01 |
| Stage2-vs-Stage4 |
9.502000E-01 |
| Stage3-vs-Stage4 |
7.580800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.138600E-01 |
| Normal-vs-AfricanAmerican |
4.608200E-01 |
| Normal-vs-Asian |
5.327200E-01 |
| Caucasian-vs-AfricanAmerican |
7.134400E-01 |
| Caucasian-vs-Asian |
6.805200E-01 |
| AfricanAmerican-vs-Asian |
5.297200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.440500E-02 |
| Normal-vs-Female |
9.811000E-01 |
| Male-vs-Female |
6.140100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.051600E-01 |
| Normal-vs-Extreme_Weight |
2.992400E-01 |
| Normal-vs-Obese |
1.238610E-01 |
| Normal-vs-Extreme_Obese |
9.987600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.804800E-01 |
| Normal_Weight-vs-Obese |
3.690200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.005200E-01 |
| Extreme_Weight-vs-Obese |
6.135600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.288400E-01 |
| Obese-vs-Extreme_Obese |
4.344600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.947600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.124000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.282980E-01 |
| Normal-vs-Age(81-100Yrs) |
3.047400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.737200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.443200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.990400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.017800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.223800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.084400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.453600E-02 |
| Normal-VS-Type2 PRCC |
5.567400E-01 |
| Normal-VS-KIRP CIMP |
6.364200E-04 |
| Normal-VS-Unclassified PRCC |
4.913200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.033990E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.703600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.036600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.01749999999556E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
2.862400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.208050E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.850600E-01 |
| Normal-vs-N1 |
8.307800E-01 |
| Normal-vs-N2 |
4.536000E-02 |
| N0-vs-N1 |
5.061800E-01 |
| N0-vs-N2 |
2.322200E-01 |
| N1-vs-N2 |
3.005000E-01 |
|
|
